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The increase in numbers of people with NCDs will place a heavy demand on societies and their health-care systems. Because the resources and the ability of healthcare systems facing this increasing demand vary by nation and the neurological diseases GBD provides the most detailed picture of burden faced by every nation, the national and regional needs can be more realistically matched. With new graphics and improved data capture, the increasing population growth and ageing means the magnitude of the global, regional, and national disease-specific burdens can be appreciated more fully than ever before. Disconcertingly, in concluding that more effective risk factor modification was required to reduce the increased burden, researchers found little or no causative explanation for the neurological diseases among the 84 risk factors that were quantified (from four hierarchies) in the neuro logical disorders GBD, apart from stroke and to a lesser extent, Alzheimer's disease and other dementias and idiopathic epilepsy. Consequently, the need to understand and develop disease-modifying strategies is of paramount importance.
A major concern in the collection of data for this study, acknowledged by the IHME researchers, is its quality and uniformity. This was especially the case with the estimates for Alzheimer's disease and other dementias. Although high-income countries had excellent coverage, low-income countries did not. From 237 literature sources, 230 ways to diagnose dementia were described and even among the 68% using the mini mental state examination, diagnostic cutoffs ranged from 18-28 of the total score of 30.
In parallel with the need to accord basic and translational research the highest priority to avert the burden on people with neurological disorders and national health systems, a matching urgency exists to correct the wide variation in national resources. In the context of the neurological disorders GBD, the global inequities of access to good-quality neurological care and the accompanying early diagnosis hinder essential interventions and the implementation of modifiable disease strategies at all levels of SDI. Not only must the increasing burden of NCDs be recognised, but also the persisting inadequacies of our collective response. For now, high-income countries with estab lished research institutions need to lead and low-income and middle-income countries
